Sample concentration and evaporation: losses and recovery

Reducing an extract to a smaller volume seems a direct way to increase concentration. It works as intended only if the analyte is conserved and made available again for measurement. Evaporation, surfaces, transfers and reconstitution can break that equivalence; matrix components may also concentrate alongside the compound of interest.

Define the reason for concentration

Clarify whether the aim is to reach a measurable range, exchange solvent or produce a volume compatible with the next step. These are related but different objectives. Concentration may increase both signal and background or interference, so it does not guarantee a proportional improvement in quantification capability.

Sander’s NIST summary on sample concentration distinguishes enrichment from solvent exchange. Define initial quantity, composition, stability and required final volume. Consider whether a simpler preparation already meets the purpose, avoiding concentration steps with no demonstrated benefit. The scope here is analytical concentration, not industrial drying or freeze-drying.

Select an approach for the sample and solvent

A gas stream promotes solvent removal from the surface; vacuum evaporation changes boiling conditions; a centrifugal concentrator combines rotation and vacuum; a rotary evaporator uses a different geometry and scale. The equipment name alone does not determine recovery or how mild the treatment is.

Assess quantity, analyte volatility, solvent composition, thermal sensitivity, vessel and vapour-handling capability. Materials, connections, traps and equipment must suit the intended use. For flammable or harmful solvents, apply laboratory and system safety and ventilation requirements; do not adapt unsuitable equipment or improvise a vessel for vacuum service.

Control variables and the endpoint

Define temperature, pressure where relevant, gas and its management if used, vessel geometry, initial volume, load, time and stopping criterion. The set temperature of the bath or chamber does not necessarily equal sample temperature. Container position and count can also change configuration behaviour.

“To dryness” and “to a defined residual volume” are different endpoints. Once solvent disappears, the residue experiences different conditions from the evaporating solution. Do not extend treatment to make all vessels look alike without assessing the effect. Establish how to detect the endpoint and handle differences between samples.

During development, vary plausibly critical parameters under a planned design consistent with ICH Q14. Do not transfer times and settings automatically between different vessels or instruments. In routine work, use approved conditions and record deviations.

Trace the different routes of loss

Missing analyte may have evaporated with solvent, been physically entrained, adsorbed or degraded, or may still be present but not redissolved. These causes do not all respond to the same intervention. Higher temperature or longer treatment can worsen the loss being addressed.

The Dixit study, 2026, demonstrates evaporative losses for specific neutral PFAS. Its operating conditions need not be transferred to pharmaceutical laboratories: the point is to verify analyte conservation rather than assume it because solvent has disappeared.

Reconstitute through to the solution actually measured

Select solvent, addition order, mixing and times according to analyte solubility and stability as well as compatibility with measurement. In the Weed, Boatman and Enders study, 2022, evaporation and reconstitution affect compounds differently. One treatment is not thereby demonstrated suitable for every analyte in a mixture.

A visually clear solution does not prove complete analyte recovery: a small quantity can remain on vessel walls or in an inconspicuous residue. If transfer is required, demonstrate its suitability and include any specified rinses in the final volume and composition. Do not add solvent by eye to recover residue and then calculate using the original nominal volume.

Distinguish solvent volume added from final solution volume. Reach the specified conditions before establishing volume and protect the preparation during holding. If filtration follows, treat it as another step to verify, not an automatic remedy for incomplete reconstitution.

Check the mass balance, not only the volume factor

For one conserved species, write m₀ = C₀ × V₀ and C_f = m₀ × r / V_f, where r is the fraction actually recovered in the final solution. Units must be consistent. Here r concerns available quantity, not an instrumental response already affected by the matrix.

Simulated numerical example. Start with 10.00 mL at 2.00 µg/mL: m₀ = 20.0 µg. Final volume is 1.00 mL. Without losses, C_f would be 20.0 µg/mL. If overall recovery into solution is 80%, recovered quantity is 16.0 µg and C_f = 16.0 µg/mL. The volume factor is 10, but actual enrichment is 16/2 = 8. Calculation alone does not locate the unrecovered 4.0 µg.

The reverse check, 16 × 1/(0.80 × 10) = 2 µg/mL, checks consistency of the assumptions; it does not measure recovery. An instrument result alone cannot separate loss from matrix effects. Appropriate blanks, comparisons and references are required; an internal standard added at the end does not automatically monitor earlier stages. The example does not authorise correction of routine results.

Document incomplete reconstitution and changes

Simulated case. Residue appears dispersed and the operator obtains the specified final volume, but a controlled development experiment finds additional analyte recoverable from the walls. The first solution may not represent the entire intended quantity. Simply reaching volume does not resolve the issue: reconstitution, transfer, stability and response require examination while initial data are retained.

Record sample identity, equipment and configuration, vessels, conditions, endpoint, times, solvents, volumes and anomalies. Compare configurations using independent preparations and representative matrices before authorising change. Do not add an improvised treatment to a routine sample to make it meet the criterion.

Integrate these controls into the traceable preparation workflow. EU GMP Chapter 6 provides the framework for records and critical examination of calculations; the PL-03 area connects complementary operations.

For the related steps, see: Analytical weighing: technique, static electricity and sample transfer.

Sources and model limitations

Consulted on 30 September 2026. NIST, Sander 2017, institutional summary; Weed et al., 2022, and Dixit et al., 2026, original studies accessed through abstracts and indexed sections, with direct PMC access limited. ICH Q14, EMA Step 5 revision 1; EU GMP Chapter 6, 2014. No PFAS conditions are proposed as a QC recipe. Table and cases are original; the balance is simulated and arithmetically checked, without an uncertainty estimate.